Come è cambiata la gestione dell'anemia per i pazienti in dialisi alla luce dello studio DOPPS

Astor B.C. , Muntner P. , Levin A. , Eustace JA , Coresh J. . Association of kidney function with anemia: the third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 2002; 162: 1401–08.

US Renal Data System. USRDS Annual Data Report, treatment modalities. Am J Kidney Dis 1994; 24(Suppl 2): S57–75.

Levin A. , Thompson C.R. , Ethier J. . Left ventricular mass index increase in early renal disease: impact of de-cline in hemoglobin. Am J Kidney Dis 1999; 34: 125–34.

Foley R.N. , Parfrey P.S. , Harnett J.D. . Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 1995; 47: 186–92.

National Kidney Foundation. K/DOQI Clinical Practice Guidelines. 2000 update. Am J Kidney Dis 2001; 37(Suppl 1): S1–238.

European Best Practice Guidelines for the management of anemia in patients with chronic renal failure. Working party for European Best Practice Guidelines for the management of anemia in patients with chronic kidney failure. Nephrol Dial Transplant 1999; 14(Suppl 5): S1–50.

Young E.W. , Goodkin D.A. , Mapes D.L. . The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international Hemodialysis study. Kidney Int 2000; 57(suppl): S74–81.

Locatelli F. , Pisoni R.L. , Akizawa T. . Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis 2004; 44(Suppl 2): S27–33.

McFarlane P. , Pisoni R.L. , Eichleay M.A. , Wald R. , Port F.K. , Mendelssohn D. . International trends in erythropoietin use and haemoglobin levels in hemodialysis patients. Kidney Int 2010; 78: 215–23.

Locatelli F. , Aljama P. , Canaud B. .; Anaemia Working Group of European Renal Best Practice (ERBP). Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. Nephrol Dial Transplant 2010; 25 (9): 2846–50.

Pisoni R.L. , Bragg-Gresham J.L. , Young E.W. . Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 94–111.

Port F.K. , Pisoni R.L. , Bommer J. . Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol 2006; 1: 246–55.

Del Vecchio L. , Cavalli A. , Tucci B. , Locatelli E. Chronic kidney disease-associated anemia: new remedies. Curr Opin Investig Drugs 2010; 11(9): 1030–38.

Pfeffer M.A. , Burdmann E.A. , Chen C.Y. . A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361(21): 2019–32.

2009 Annual Report of the Dialysis Outcomes and Practice Patterns Study: Hemodialysis Data 1999–2008. Arbor Research Collaborative for Health, Ann Arbor, MI. http://www.dopps.org/annualreport/html/iron_iv_c_mostrec2009.htm (accesso il 28 Settembre 2010).

Locatelli F. , Pisoni R.L. , Combe C. . Anemia in hemodialysis patients of five European Countries: Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 121–32.

Locatelli F. , Andrulli S. , Del Vecchio L Difficulties of implementing clinical guidelines in medical practice. Nephrol Dial Transplant 2000; 15: 1284–87.

Goodkin D.A. , Bragg-Gresham J.L. , Koenig K.G. . Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270–77.

Besarab A. , Bolton W.K. , Browne J.K. . The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339(9): 584–90.

Singh A.K. . Does the TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol 2010; 21: 2–6.